CDC would run national HPV vaccine awareness campaign under new bill

What does this do?

HR 6561 directs the CDC to run a national public awareness campaign about HPV, a virus linked to six types of cancer including cervical and throat cancer. The campaign would spread accurate information about the HPV vaccine, counter misinformation, and encourage vaccination through social media, TV, radio, and trusted community figures. Grants would go to state, local, and tribal health departments to improve vaccine access and information in underserved communities.

Who does it affect?

The bill primarily affects public health agencies, doctors, schools, and community organizations that would carry out the campaign. It directly targets families with children ages 9 to 12, adults up to age 45, Black and Hispanic women, people in rural areas, men, and active-duty military members and veterans.

Why does it matter?

The bill focuses on communities where vaccination rates are low or HPV-related cancer rates are high, which shaped the decision to fund targeted outreach rather than broad general awareness alone. An existing breast and cervical cancer screening program would also see its authorized funding raised to $300 million per year through 2030.

What does it cost, and who pays?

Congress would authorize up to $5 million per year from 2026 through 2030 for the HPV campaign. The existing breast and cervical cancer screening program would have its authorized funding raised to $300 million per year through 2030.

Where does it stand?